Ottobock stock

OBCK · Xetra · EUR

Compare Ottobock
€37.70Change from previous close: −1.18%Absolute change: −€0.45

Close · November 20, 2026

Price history

−48.36% over the period

1 year: from €73.00 (November 20, 2025) to €37.70 (November 20, 2026), −48.36%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 20, 2026€37.70
October 30, 2026€48.15
September 30, 2026€53.10
August 31, 2026€59.80
July 31, 2026€56.10
June 30, 2026€50.80
May 29, 2026€52.80
April 30, 2026€58.30
March 31, 2026€51.80
February 27, 2026€57.00
January 30, 2026€60.75
December 30, 2025€65.25
November 28, 2025€73.95
November 20, 2025€73.00

At a glance

  • The company

    Develop, produce and distribute prosthetics, orthotics, mobility aids and exoskeletons for people with disabilities worldwide

  • Latest results

    Quarter to June 30, 2026 · EPS €1.06

TickerLandia's take on Ottobock

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low€37.50
52-wk high€65.00

−42.00% from the 52-week high

Analysts · 8 analysts

Average target€72.25+91.64% vs. price

Buy 7 · Hold 1 · Sell 0 · Strong buy

TickerLandia Fingerprint: Ottobock

Compared with similar companies: very weak momentum and very low price.

Financials and price compared with 34 companies in the medical instruments & supplies industry, worldwide. Momentum and risk compared with 1,160 European stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Ottobock is cheaper than similar companies

Ottobock's P/E (trailing 12 months): 19.0, −24% against the median of a group of 9 similar companies (25.1).

Compared with 9 similar companies

Ottobock's metrics compared with similar companies
MetricOttobockPosition in the groupBand
P/E (trailing 12 months)19.0Low
Forward P/E10.7Low
Operating margin18.7%High
ROE41.5%High
Debt/equity2.72High

Grey band: the middle half of the group; tick: the median; dot: Ottobock. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

€458.1M

Latest quarter · Q2 2026

Net income

€48.8M

Latest quarter · Q2 2026

Quarterly net margin

10.7%

Latest quarter · Q2 2026

Numbers and valuation

Full valuation
Market cap
€2.44B
P/E
19.0
EPS
€2.01
Volume
79.27K
Daily trading
€3.02M
Dividend yield
2.57%
Last ex-dividend on May 20, 2026

How Ottobock is changing

All results
  • Revenue grew 8.0% a year on average over the last 3 years

  • Operating margin rose from 5.1% to 14.1%

  • Shares outstanding up 1,047.0% in 3 years

Returns

Ottobock returns with dividends

€1,000 invested in Ottobock 1 year ago, on November 20, 2025, would be worth €526 today with dividends reinvested: −47.44% in total, −47.44% per year. On price alone it would be €516 (−48.36%).

PeriodOttobockDAX€1,000 becomes
1 month−26.22%−1.98%€738
6 months−31.33%+0.26%€687
Year to date−42.22%+1.28%€578
1 year−47.44%+6.55%€526

Over the last 6 months it has done better than 5% of the stocks in the Healthcare sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. DAX: with dividends. Calculate your investment

The chart in detail

Ottobock: technical analysis

Ottobock is in a downtrend: the price is below its 50- and 200-session moving averages, and the 200-session average is falling. The price is 50.2% below its all-time closing high (€75.70, November 25, 2025).

Trend
Downward
RSI (14 sessions)
19
Below 30: a strong fall in a short time
vs 200-session average
−30.39%

Active signals

  • RSI below 30: the stock has fallen a lot in a short time.

    since November 12, 2026

Support and resistance

Price areas where Ottobock has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance€55.00+45.89%5 touches, last on October 14, 2026
  2. Resistance€53.66+42.34%4 touches, last on September 15, 2026
  3. Resistance€49.68+31.78%5 touches, last on November 5, 2026
  4. Last price€37.70
  5. No support below: the price is near the lows of the year

Volatility and risk

Over the last year it has moved less than the DAX.

Beta (1 year) vs DAX
0.70
Volatility (60 sessions, annualised)
42.6%
Largest fall in the last year
−50.20%

Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

The company

Ottobock and its competitors

Prosthetics form the core of Ottobock SE & Co. KGaA, which designs, manufactures and sells medical technology for people with disabilities. Its range runs from arm, hand and leg prostheses, including myoelectric and microprocessor-driven models, to socket components such as liners and cosmetic covers. Orthotic devices, neuro-rehabilitation stimulators, wheelchairs, seating and clinic planning services complete the offer, and the group also rents out some equipment. Its customers include patients with limb loss, vascular disease, cancer-related amputations and neurological conditions such as stroke or multiple sclerosis.

Headquarters
Duderstadt, Germany
Employees
9,455
Founded
1919
Chief executive
Oliver Jakobi
Ottobock and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
OttobockOBCK$2.68B18.7%19.0−31.33%
Carl Zeiss MeditecAFX$3.07B7.2%23.3+24.32%
AddLifeALIF.B$2.11B8.9%33.5+17.73%
Bonesupport HoldingBONEX$2.03B25.5%78.1+25.60%
Tecan GroupTECN$3.58B4.9%—+64.44%
SCHOTT Pharma1SXP$3.74B16.4%25.1+34.04%

Same industry or related industries, similar size. Compare Ottobock with its competitors · Full profile